Brain regional iron contents in progressive supranuclear palsy-Reference-Cited by-同舟云学术

Brain regional iron contents in progressive supranuclear palsy

Published:2017-12 Issue: Volume:45 Page:28-32
ISSN:1353-8020
Container-title:Parkinsonism & Related Disorders
language:en
Short-container-title:Parkinsonism & Related Disorders

Author:

Lee Seung Ha,Lyoo Chul Hyoung,Ahn Sung Jun,Rinne Juha O.,Lee Myung Sik

Funder

Samil Pharm, Co, LTD

Publisher

Elsevier BV

Subject

Clinical Neurology,Geriatrics and Gerontology,Neurology

Reference30 articles.

1. Quantitative assessment of subcortical atrophy and iron content in progressive supranuclear palsy and parkinsonian variant of multiple system atrophy;Lee;J. Neurol.,2013

2. Brain iron deposition fingerprints in Parkinson's disease and progressive supranuclear palsy;Boelmans;Mov. Disord.,2012

3. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop;Litvan;Neurology,1996

4. P.S.P.S.G. Movement Disorder Society-endorsed, the phenotypic spectrum of progressive supranuclear palsy: a retrospective multicenter study of 100 definite cases;Respondek;Mov. Disord.,2014

5. Regional specificity of MRI contrast parameter changes in normal ageing revealed by voxel-based quantification (VBQ);Draganski;Neuroimage,2011

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Irony of Iron: The Element with Diverse Influence on Neurodegenerative Diseases;International Journal of Molecular Sciences;2024-04-12

2. Tau accumulation is associated with dopamine deficiency in vivo in four-repeat tauopathies;European Journal of Nuclear Medicine and Molecular Imaging;2024-02-17

3. Genome-wide screening in pluripotent cells identifies Mtf1 as a suppressor of mutant huntingtin toxicity;Nature Communications;2023-07-05

4. Association between Beta Oscillations from Subthalamic Nucleus and Quantitative Susceptibility Mapping in Deep Gray Matter Structures in Parkinson’s Disease;Brain Sciences;2023-01-01

5. Characterization and diagnostic potential of R2* in early-stage progressive supranuclear palsy variants;Parkinsonism & Related Disorders;2022-08